28 Results for "

TXA2 Receptor

" in MedChemExpress (MCE) Product Catalog:
Products (28)

28 Results for "TXA2 Receptor" in MCE Product Catalog:

16
16 Publications Verification
Cat. No.: HY-108566
CAS No.: 56985-40-1
Purity:  ≥98.0%
Synonyms: 9,11-Methanoepoxy PGH2
Research Areas:  

Cardiovascular Disease

U-46619 (9,11-Methanoepoxy PGH2) is a stable analogue of Thromboxane A2 (HY-113350) (TXA2) and acts as a potent TXA2 (TP) agonist. U-46619 also is a RhoA agonist. U-46619 stimulates the activation of RhoA through TXA2 receptor activation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-16991
CAS No.: 165538-40-9
Synonyms: S-18886
Terutroban (S-18886) is a selective and orally active thromboxane-prostaglandin (TP) receptor antagonist with an IC50 of 16.4 nM. Terutroban inhibits TXA2 and prostaglandin endoperoxide receptors. Terutroban is a potent antithrombotic agent and possesses anti-atherosclerotic and anti-vasoconstrictor properties .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-105218
CAS No.: 143443-90-7
Purity:  99.65%
Synonyms: BMS-180291
Ifetroban (BMS-180291) is an orally active antagonist of thromboxane A2 (TXA2) or prostaglandin H2 (PGH2) receptor. Ifetroban shows antiplatelet activity, and inhibits tumor cell migration without affecting cell proliferation. Ifetroban can be used for myocardial ischemia, hypertension, stroke, thrombosis, cardiomyopathy research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-105218A
CAS No.: 156715-37-6
Purity:  99.83%
Synonyms: BMS-180291 sodium
Ifetroban (BMS-180291) sodium is an orally active antagonist of thromboxane A2 (TXA2) or prostaglandin H2 (PGH2) receptor. Ifetroban sodium shows antiplatelet activity, and inhibits tumor cell migration without affecting cell proliferation. Ifetroban sodium can be used for myocardial ischemia, hypertension, stroke, thrombosis, cardiomyopathy research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-16991A
CAS No.: 609340-89-8
Synonyms: S-18886 sodium
Terutroban (S-18886) sodium is a selective and orally active thromboxane-prostaglandin (TP) receptor antagonist with an IC50 of 16.4 nM. Terutroban sodium inhibits TXA2 and prostaglandin endoperoxide receptors. Terutroban sodium is a potent antithrombotic agent and possesses anti-atherosclerotic and anti-vasoconstrictor properties .
loading...
    loading...
Cat. No.: HY-129851
CAS No.: 2055599-51-2
Purity:  98.58%
Research Areas:  

Cardiovascular Disease

NTP42 is a thromboxane A2 (TXA2) receptor antagonist with an IC50 of 3.278 nM for antagonizing T prostanoid receptor (TP)- mediated [Ca 2+] mobilization following stimulation of cells with the alternative TP agonist U46619 . NTP42 can be used for the treatment of pulmonary arterial hypertension (PAH) .
loading...
    loading...
Cat. No.: HY-121018
CAS No.: 79094-20-5
Synonyms: BM-13505; SKF 96148
Research Areas:  

Cardiovascular Disease

Daltroban (BM-13505) is a selective and specific thromboxane A2 (TXA2) receptor antagonist. Daltroban increase intracellular calcium in vascular smooth muscle cells. Daltroban shows protective effect in reperfusion injury .
loading...
    loading...
Cat. No.: HY-B1735
CAS No.: 32828-81-2
Research Areas:  

Cardiovascular Disease

Picotamide is a combined inhibitor of thromboxane A2 (TxA2) synthase and receptor. Picotamide has antiplatelet activity. Picotamide promotes the reduction of microalbuminuria and the inhibition of growth of carotid plaques in diabetes. Picotamide can be used for researching acute or chronic cardiovascular diseases .
loading...
    loading...
Cat. No.: HY-118044
CAS No.: 133538-58-6
Research Areas:  

Cardiovascular Disease

I-SAP is a radioiodinated TXA2/PGH2 receptor antagonist. The bind between I-SAP and the receptors, is inhibited by the histidine modifying reagent diethyl-pyrocarbonate (DEPC) .
loading...
    loading...
Cat. No.: HY-135447
CAS No.: 284464-46-6
BM-531 is a dual-acting agent for thromboxane receptor (TXA2) antagonism and thromboxane synthase inhibition. BM-531 exerts anti-aggregatory effects on human citrated platelet-rich plasma (PRP), inhibiting Arachidonic acid (HY-109590A)-induced aggregation with an ED100 of 0.125 μM and U-46619 (HY-108566)-induced aggregation with an ED50 of 0.482 μM. BM-531 inhibits high-K +-induced contraction of porcine uterine smooth muscle .
loading...
    loading...
Cat. No.: HY-U00072
CAS No.: 207987-59-5
RS-601 is a novel leukotriene D4 (LTD4)/thromboxane A2 (TxA2) dual receptor antagonist, with antiasthmatic activities.
loading...
    loading...
Cat. No.: HY-116281
CAS No.: 147332-48-7
Research Areas:  

Cardiovascular Disease

ICI D1542 is a selective and potent inhibitor of thromboxane A2 (TXA2) synthase and the thromboxane A2 receptor (TP-receptor). ICI D1542 is effective at preventing thrombus formation by redirection of arachidonic acid metabolism .
loading...
    loading...
Cat. No.: HY-101700
CAS No.: 141335-10-6
Research Areas:  

Cardiovascular Disease

LCB-2853 is an antagonist of thromboxane A2 (TXA2) receptor, with antiplatelet and antithrombotic activities.
loading...
    loading...
Cat. No.: HY-118920
CAS No.: 82337-14-2
Research Areas:  

Cardiovascular Disease

SQ 26655 is a TxA2 receptor agonist. SQ 26655 induces human platelet aggregation .
loading...
    loading...
Cat. No.: HY-19129
CAS No.: 129648-96-0
Research Areas:  

Cardiovascular Disease

KT2-962 is a thromboxane A2 (TXA2) receptor antagonist and potent hydroxyl radical scavenger (IC50=500 nM). KT2-962 reduces myocardial infarct size and ventricular fibrillation. KT2-962 demonstrates cardioprotective effect in a canine ischemia/reperfusion model. KT2-962 is promising for research of myocardial ischemia-reperfusion injury and TXA2-mediated vascular diseases .
loading...
    loading...
Cat. No.: HY-U00355
CAS No.: 179102-65-9
Synonyms: YM-57158
YM158 free base is a potent and selective LTD4 and TXA2 receptor antagonist with pA2 values of about 8.87 and 8.81, respectively.
loading...
    loading...
Cat. No.: HY-169803
CAS No.: 113243-00-8
Research Areas:  

Cardiovascular Disease

L-657926 is a stereoselective antagonist of the thromboxane A2 (TxA2) receptor, composed of (-)-9-chlorobenzyl-6-fluoro-1,2,3,4-tetrahydrocarbazol-1-yl acetic acid and (+)-9-chlorobenzyl-6-fluoro-1,2,3,4-tetrahydrocarbazol-l-yl acetic acid. The IC50s of (-) and (+) configurations for TxA2 are 0.27 nM and 124 nM, respectively.
loading...
    loading...
Cat. No.: HY-19249
CAS No.: 146731-14-8
Z-335 sodium is an orally active thromboxane a2 (TXA2) receptor antagonist, with IC50 values of 29.9 nM and 32.5 nM for human and Guinea pig platelets, respectively .
loading...
    loading...
Cat. No.: HY-158332
CAS No.: 72131-33-0
Purity:  99.29%
Synonyms: SKF-95587; BM-13177
Research Areas:  

Cardiovascular Disease

Sulotroban (SKF-95587; BM-13177) is a selective antagonist for thromboxane A2 receptor (TXA2 Receptor). Sulotroban exhibits inhibitory activity against carbocyclic thromboxane A2- and endoperoxide-induced vasoconstrictor. Sulotroban inhibits platelets aggregation .
loading...
    loading...
Cat. No.: HY-105120
CAS No.: 85505-64-2
Synonyms: GR 32191
Research Areas:  

Others

Vapiprost (GR 32191) is a thromboxane A2 receptor (TXA2 Receptor) antagonist. Vapiprost hydrochloride (GR 32191 hydrochloride) inhibits the aggregation and ATP release stimulated with U-46619, collagen or arachidonic acid (AA) at an IC50 of less than 2.1×10 -8 M .
loading...
    loading...